[go: up one dir, main page]

ATE272626T1 - Verfahren zur herstellung von pyrazolopyrimidinonen - Google Patents

Verfahren zur herstellung von pyrazolopyrimidinonen

Info

Publication number
ATE272626T1
ATE272626T1 AT01936737T AT01936737T ATE272626T1 AT E272626 T1 ATE272626 T1 AT E272626T1 AT 01936737 T AT01936737 T AT 01936737T AT 01936737 T AT01936737 T AT 01936737T AT E272626 T1 ATE272626 T1 AT E272626T1
Authority
AT
Austria
Prior art keywords
pyrazolopyrimidinones
producing
producing pyrazolopyrimidinones
Prior art date
Application number
AT01936737T
Other languages
English (en)
Inventor
Peter James Dunn
Catherine Dunne
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26244540&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE272626(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0015472A external-priority patent/GB0015472D0/en
Priority claimed from GB0105857A external-priority patent/GB0105857D0/en
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE272626T1 publication Critical patent/ATE272626T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT01936737T 2000-06-22 2001-06-11 Verfahren zur herstellung von pyrazolopyrimidinonen ATE272626T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0015472A GB0015472D0 (en) 2000-06-22 2000-06-22 Novel process for the preparation of pyrazolopyrimidinones
GB0105857A GB0105857D0 (en) 2001-03-09 2001-03-09 Novel process for the preparation of pyrazolopyrimidinones
PCT/IB2001/001050 WO2001098284A1 (en) 2000-06-22 2001-06-11 Process for the preparation of pyrazolopyrimidinones

Publications (1)

Publication Number Publication Date
ATE272626T1 true ATE272626T1 (de) 2004-08-15

Family

ID=26244540

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01936737T ATE272626T1 (de) 2000-06-22 2001-06-11 Verfahren zur herstellung von pyrazolopyrimidinonen

Country Status (29)

Country Link
EP (1) EP1292586B1 (de)
JP (1) JP2004501142A (de)
KR (1) KR100525698B1 (de)
CN (1) CN100338047C (de)
AP (1) AP2001002194A0 (de)
AR (1) AR028740A1 (de)
AT (1) ATE272626T1 (de)
AU (2) AU6259701A (de)
BR (1) BR0111581A (de)
CA (1) CA2411961C (de)
CZ (1) CZ20024176A3 (de)
DE (1) DE60104691T2 (de)
DK (1) DK1292586T3 (de)
DO (1) DOP2001000190A (de)
ES (1) ES2223863T3 (de)
HK (1) HK1054926A1 (de)
HU (1) HUP0301183A3 (de)
IL (1) IL153532A0 (de)
MX (1) MXPA02012884A (de)
MY (1) MY124903A (de)
PA (1) PA8519801A1 (de)
PE (1) PE20020105A1 (de)
PL (1) PL359651A1 (de)
PT (1) PT1292586E (de)
SV (1) SV2002000503A (de)
TN (1) TNSN01093A1 (de)
TR (1) TR200401983T4 (de)
WO (1) WO2001098284A1 (de)
YU (1) YU93902A (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2310144B1 (es) * 2007-06-15 2010-01-12 Galenicum Health, S.L. Intermedios para la preparacion de un inhibidor de la fosfodiesterasa tipo 5.
US8410098B2 (en) 2007-12-28 2013-04-02 Topharman Shanghai Co., Ltd. N-{1-[3-(2-ethoxy-5-(4-ethylpiperazinyl)sulfonylphenyl)-4,5-dihydro-5-OXO-1,2,4-triazin-6-yl]ethyl}butyramide, the preparation method and use thereof
CN101747282A (zh) * 2008-12-10 2010-06-23 上海特化医药科技有限公司 一类含有嘧啶酮苯基的化合物、其药物组合物及其制备方法和用途
CA2770471A1 (en) 2009-08-07 2011-02-10 Ranbaxy Laboratories Limited Processes for the preparation of vardenafil
EP2523664A4 (de) * 2010-01-13 2013-06-26 Tempero Pharmaceuticals Inc Verbindungen und verfahren
MX2010006227A (es) 2010-06-07 2011-12-14 World Trade Imp Exp Wtie Ag Nuevos derivados 1,4-diazepanos, inhibidores de pde-5.
FR2970967B1 (fr) 2011-01-27 2013-02-15 Pf Medicament Derives de type azaindazole ou diazaindazole comme medicament
EP2689778A1 (de) 2012-07-27 2014-01-29 Pierre Fabre Medicament Azaindazol- oder Diazaindazol-Derivate zur Behandlung von Schmerzen
EP2689779A1 (de) 2012-07-27 2014-01-29 Pierre Fabre Medicament Azaindazol- oder Diazaindazol-Derivate zur Behandlung eines Krebses, der TRK überexprimiert
ES2968172T3 (es) * 2016-10-24 2024-05-08 Fmc Corp Oxadiazoles que tienen actividad fungicida
KR20210098949A (ko) * 2018-10-01 2021-08-11 피아이 인더스트리스 엘티디. 새로운 옥사디아졸

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9822238D0 (en) * 1998-10-12 1998-12-09 Pfizer Ltd Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof
EP1002798A1 (de) * 1998-11-20 2000-05-24 Orchid Chemicals & Pharmaceuticals Ltd. Verfahren zur Herstellung von therapeutisch aktiven Pyrazolopyrimidinonderivaten

Also Published As

Publication number Publication date
PL359651A1 (en) 2004-08-23
DE60104691T2 (de) 2005-01-13
HK1054926A1 (en) 2003-12-19
CA2411961C (en) 2007-02-06
BR0111581A (pt) 2003-03-25
AP2001002194A0 (en) 2002-12-21
MY124903A (en) 2006-07-31
PE20020105A1 (es) 2002-02-21
HUP0301183A3 (en) 2006-02-28
CN100338047C (zh) 2007-09-19
PT1292586E (pt) 2004-11-30
JP2004501142A (ja) 2004-01-15
AU6259701A (en) 2002-01-02
PA8519801A1 (es) 2002-04-25
ES2223863T3 (es) 2005-03-01
WO2001098284A1 (en) 2001-12-27
TR200401983T4 (tr) 2004-09-21
AU2001262597B2 (en) 2005-10-20
EP1292586B1 (de) 2004-08-04
AR028740A1 (es) 2003-05-21
IL153532A0 (en) 2003-07-06
KR20030031912A (ko) 2003-04-23
DK1292586T3 (da) 2004-08-30
MXPA02012884A (es) 2003-05-14
CZ20024176A3 (cs) 2004-01-14
YU93902A (sh) 2005-11-28
CA2411961A1 (en) 2001-12-27
EP1292586A1 (de) 2003-03-19
SV2002000503A (es) 2002-07-03
HUP0301183A2 (hu) 2003-08-28
CN1437589A (zh) 2003-08-20
TNSN01093A1 (fr) 2005-11-10
KR100525698B1 (ko) 2005-11-03
DOP2001000190A (es) 2002-05-15
DE60104691D1 (de) 2004-09-09

Similar Documents

Publication Publication Date Title
ATE386736T1 (de) Verfahren zur herstellung von benzimidazol-2-yl - chinolinonderivaten
DE60221399D1 (de) Verfahren zur herstellung von mitteldistillaten
ATE403641T1 (de) Verfahren zur herstellung von o- desmethylvenlafaxin
DE60107450D1 (de) Verfahren zur herstellung von fluoroelastomeren
AT7110U9 (de) Verfahren zur herstellung von amlodipinmaleat
DE60033061D1 (de) Verfahren zur herstellung von siloxancopolycarbonaten
DE60109101D1 (de) Verfahren zur Herstellung von Zahnnuten
ATE298788T1 (de) Verfahren zur herstellung von infektiösen reoviren
DE60230908D1 (de) Verfahren zur herstellung von polyarylenethern
ATE281447T1 (de) Verfahren zur herstellung von citalopram
ATE388026T1 (de) Verfahren zur herstellung von oberflächenelementen
ATE331804T1 (de) Verfahren zur herstellung von ansamitocin
DE60126336D1 (de) Verfahren zur herstellung von hochreinen durchscheinenden perfluorelastomer-gegenständen
DE50101607D1 (de) Verfahren zur herstellung von bisphenolen
ATE397608T1 (de) Verfahren zur herstellung von anagrelid
ATE328885T1 (de) Verfahren zur herstellung von sulfonamid- substituierten imidazotriazinonen
DE50102444D1 (de) Verfahren zur herstellung von isocyanatoorganosilanen
ATE316518T1 (de) Verfahren zur herstellung von (r)-2-alkyl-3- phenyl-1-propanolen
DE60103173D1 (de) Verfahren zur herstellung von 3-amino-2-chlor-4-methylpyridin
DE50111560D1 (de) Verfahren zur herstellung von guerbetalkoholen
ATE441662T1 (de) Verfahren zur herstellung von echinocandinderivaten
ATE287870T1 (de) Verfahren zur herstellung von phenethylamin- derivaten
ATE272626T1 (de) Verfahren zur herstellung von pyrazolopyrimidinonen
DE50211941D1 (de) Verfahren zur Herstellung vergrabener Bereiche
ATE389645T1 (de) Verfahren zur herstellung von citalopram

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1292586

Country of ref document: EP

REN Ceased due to non-payment of the annual fee